Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECA: Aspirin in cSDH
NCT03120182Completed
- Sponsor
- University Hospital Basel
- Start
- Feb 2018
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in cardiovascular diseases (CVD) comparing Aspirin Arm with Placebo Arm (2 arms). Primary endpoint: Revision surgery due to a recurrent subdural hematoma at 6 months. Started Feb 2018; status: completed.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT03120182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03120182.